Leptin-dependent and leptin-independent paracrine effects of perivascular adipose tissue on neointima formation. 2013

Marco R Schroeter, and Norman Eschholz, and Sebastian Herzberg, and Isabel Jerchel, and Maren Leifheit-Nestler, and Frauke S Czepluch, and Georgios Chalikias, and Stavros Konstantinides, and Katrin Schäfer
Department of Cardiology and Pulmonary Medicine, University Medical Center Goettingen, Georg August University of Goettingen, Goettingen, Germany.

OBJECTIVE Clinical and experimental evidence suggests that periadventitial adipose tissue may modulate vascular lesion formation. The aim of this study was to determine the role of perivascular leptin expression on neointima formation and to differentiate it from local inflammation and systemically elevated leptin levels. RESULTS Increased neointima formation after carotid artery injury was observed in hyperleptinemic, diet-induced obese wild-type mice, but not in leptin-deficient ob/ob mice. High-fat diet was associated with increased leptin expression in visceral adipose tissue (VAT) as well as in perivascular adipose tissue. Perivascular leptin overexpression achieved by adenoviral vectors enhanced intimal cell proliferation and neointima formation in wild-type mice, but not in leptin receptor-deficient mice. Perivascular transplantation of VAT from high-fat diet-induced obese wild-type mice around the carotid artery of immunodeficient mice also promoted neointima formation, without affecting body weight or systemic leptin levels, and this effect was absent, if VAT from ob/ob mice was used. On the contrary, perivascular transplantation of VAT from ob/ob mice fed high-fat diet, characterized by marked immune cell accumulation, promoted neointimal hyperplasia also in the absence of leptin. In vitro, recombinant leptin and VAT-conditioned medium increased human arterial smooth muscle cell proliferation in a (partly) leptin-dependent manner. CONCLUSIONS Our findings suggest that locally elevated leptin levels may promote neointima formation, independent of obesity and systemic hyperleptinemia, but also underline the importance of perivascular inflammation in mediating the increased cardiovascular risk in obesity.

UI MeSH Term Description Entries
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008820 Mice, Obese Mutant mice exhibiting a marked obesity coupled with overeating, hyperglycemia, hyperinsulinemia, marked insulin resistance, and infertility when in a homozygous state. They may be inbred or hybrid. Hyperglycemic Mice,Obese Mice,Mouse, Hyperglycemic,Mouse, Obese,Hyperglycemic Mouse,Mice, Hyperglycemic,Obese Mouse
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D050152 Intra-Abdominal Fat Fatty tissue inside the ABDOMINAL CAVITY, including visceral fat and retroperitoneal fat. It is the most metabolically active fat in the body and easily accessible for LIPOLYSIS. Increased visceral fat is associated with metabolic complications of OBESITY. Abdominal Visceral Fat,Fat, Intra-Abdominal,Intra-Abdominal Adipose Tissue,Retroperitoneal Adipose Tissue,Retroperitoneal Fat,Visceral Adipose Tissue,Visceral Fat,Abdominal Visceral Fats,Adipose Tissue, Intra-Abdominal,Adipose Tissue, Retroperitoneal,Adipose Tissue, Visceral,Fat, Abdominal Visceral,Fat, Intra Abdominal,Fat, Retroperitoneal,Fat, Visceral,Fats, Abdominal Visceral,Fats, Intra-Abdominal,Fats, Retroperitoneal,Fats, Visceral,Intra Abdominal Adipose Tissue,Intra Abdominal Fat,Intra-Abdominal Fats,Retroperitoneal Fats,Visceral Fats
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D058426 Neointima The new and thickened layer of scar tissue that forms on a PROSTHESIS, or as a result of vessel injury especially following ANGIOPLASTY or stent placement. Neointima Formation,Formation, Neointima,Neointimas

Related Publications

Marco R Schroeter, and Norman Eschholz, and Sebastian Herzberg, and Isabel Jerchel, and Maren Leifheit-Nestler, and Frauke S Czepluch, and Georgios Chalikias, and Stavros Konstantinides, and Katrin Schäfer
December 2019, International journal of molecular sciences,
Marco R Schroeter, and Norman Eschholz, and Sebastian Herzberg, and Isabel Jerchel, and Maren Leifheit-Nestler, and Frauke S Czepluch, and Georgios Chalikias, and Stavros Konstantinides, and Katrin Schäfer
October 2017, British journal of pharmacology,
Marco R Schroeter, and Norman Eschholz, and Sebastian Herzberg, and Isabel Jerchel, and Maren Leifheit-Nestler, and Frauke S Czepluch, and Georgios Chalikias, and Stavros Konstantinides, and Katrin Schäfer
January 2011, Pharmacological research,
Marco R Schroeter, and Norman Eschholz, and Sebastian Herzberg, and Isabel Jerchel, and Maren Leifheit-Nestler, and Frauke S Czepluch, and Georgios Chalikias, and Stavros Konstantinides, and Katrin Schäfer
January 2012, Vascular pharmacology,
Marco R Schroeter, and Norman Eschholz, and Sebastian Herzberg, and Isabel Jerchel, and Maren Leifheit-Nestler, and Frauke S Czepluch, and Georgios Chalikias, and Stavros Konstantinides, and Katrin Schäfer
January 2012, Frontiers in pharmacology,
Marco R Schroeter, and Norman Eschholz, and Sebastian Herzberg, and Isabel Jerchel, and Maren Leifheit-Nestler, and Frauke S Czepluch, and Georgios Chalikias, and Stavros Konstantinides, and Katrin Schäfer
February 2024, Journal of cardiovascular translational research,
Marco R Schroeter, and Norman Eschholz, and Sebastian Herzberg, and Isabel Jerchel, and Maren Leifheit-Nestler, and Frauke S Czepluch, and Georgios Chalikias, and Stavros Konstantinides, and Katrin Schäfer
May 2019, Scientific reports,
Marco R Schroeter, and Norman Eschholz, and Sebastian Herzberg, and Isabel Jerchel, and Maren Leifheit-Nestler, and Frauke S Czepluch, and Georgios Chalikias, and Stavros Konstantinides, and Katrin Schäfer
April 2009, Journal of hypertension,
Marco R Schroeter, and Norman Eschholz, and Sebastian Herzberg, and Isabel Jerchel, and Maren Leifheit-Nestler, and Frauke S Czepluch, and Georgios Chalikias, and Stavros Konstantinides, and Katrin Schäfer
August 2011, Endocrine reviews,
Marco R Schroeter, and Norman Eschholz, and Sebastian Herzberg, and Isabel Jerchel, and Maren Leifheit-Nestler, and Frauke S Czepluch, and Georgios Chalikias, and Stavros Konstantinides, and Katrin Schäfer
December 1997, The Journal of clinical investigation,
Copied contents to your clipboard!